ABIRATERONE ACETATE
- Product NDC
- 42291-073
- 11-digit product format
- 422910073
- Labeler code
- 42291
- Product ID
- 42291-073_ec19a5c9-a06e-4082-e053-2995a90aba71
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ABIRATERONE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- AvKARE
- Application
- ANDA208327
- Marketing category
- ANDA
- Marketing start
- 2021-04-29
- Marketing end
- 0000-00-00
- Substance
- ABIRATERONE ACETATE
- Active strength
- 500 mg/1
- Pharmacologic classes
- Cytochrome P450 17A1 Inhibitor [EPC], Cytochrome P450 17A1 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 42291-073-60 | 42291007360 | 60 TABLET in 1 BOTTLE (42291-073-60) | 60 tablet | 2021-04-29 | 0000-00-00 | No | No | Current |